SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+18%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$271M
AUM Growth
+$271M
(+46%)
Cap. Flow
+$68.2M
Cap. Flow
% of AUM
25.15%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
68
New
19
Increased
25
Reduced
11
Closed
9
Top Buys
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
Sanofi
SNY
|
$5.76M |
| 4 |
CELG
Celgene Corp
CELG
|
$5.66M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.21M |
Top Sells
| 1 |
Cigna
CI
|
$7.6M |
| 2 |
UnitedHealth
UNH
|
$6.98M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$5.38M |
| 4 |
Zimmer Biomet
ZBH
|
$2.07M |
| 5 |
Intuitive Surgical
ISRG
|
$2M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Energy | 1.43% |
| 3 | Utilities | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
26
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.06M | 1.86% |
30,000
+25,000
| +500% | +$4.21M |
|
|
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
| $5.03M | 1.85% |
160,000
+12,199
| +8% | +$384K |
|
28
Bausch Health
BHC
$2.74B
| $4.94M | 1.82% |
200,000
+50,000
| +33% | +$1.24M |
|
29
Smith & Nephew
SNN
$16.3B
| $4.41M | 1.63% |
110,000
+34,000
| +45% | +$1.36M |
|
30
Viatris
VTRS
$12.3B
| $4.25M | 1.57% |
150,000
+93,814
| +167% | +$2.66M |
|
31
Centene
CNC
$14.3B
| $4.25M | 1.57% |
80,000
+50,550
| +172% | +$2.68M |
|
32
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4M | 1.47% |
45,000
-10,000
| -18% | -$888K |
|
33
Illumina
ILMN
$15.8B
| $3.88M | 1.43% |
12,500
-2,500
| -17% | -$777K |
|
|
LHCG
34
DELISTED
LHC Group LLC
LHCG
| $3.88M | 1.43% |
35,000
-5,000
| -13% | -$554K |
|
35
Labcorp
LH
$23.1B
| $3.83M | 1.41% |
+25,000
| New | +$3.83M |
|
36
Agilent Technologies
A
$35.7B
| $3.62M | 1.33% |
45,000
-2,148
| -5% | -$173K |
|
37
Biogen
BIIB
$19.4B
| $3.55M | 1.31% |
15,000
-5,000
| -25% | -$1.18M |
|
38
AbbVie
ABBV
$372B
| $3.43M | 1.26% |
+42,500
| New | +$3.43M |
|
39
Teva Pharmaceuticals
TEVA
$21.1B
| $3.37M | 1.24% |
215,000
+30,000
| +16% | +$470K |
|
40
Qiagen
QGEN
$10.1B
| $3.25M | 1.2% |
80,000
-30,800
| -28% | -$1.25M |
|
|
NVRO
41
DELISTED
NEVRO CORP.
NVRO
| $3.13M | 1.15% |
+50,000
| New | +$3.13M |
|
42
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.07M | 1.13% |
+225,000
| New | +$3.07M |
|
43
Edwards Lifesciences
EW
$47.8B
| $3.06M | 1.13% |
+16,000
| New | +$3.06M |
|
|
BLUE
44
DELISTED
bluebird bio
BLUE
| $2.79M | 1.03% |
+17,705
| New | +$2.79M |
|
45
Dentsply Sirona
XRAY
$2.85B
| $2.73M | 1% |
+55,000
| New | +$2.73M |
|
|
VAR
46
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.69M | 0.99% |
+19,000
| New | +$2.69M |
|
|
AMED
47
DELISTED
Amedisys
AMED
| $2.47M | 0.91% |
20,000
| – | – |
|
48
Fresenius Medical Care
FMS
$15.1B
| $2.03M | 0.75% |
+50,000
| New | +$2.03M |
|
|
BPMC
49
DELISTED
Blueprint Medicines
BPMC
| $2M | 0.74% |
+25,000
| New | +$2M |
|
50
Perrigo
PRGO
$3.27B
| $1.93M | 0.71% |
+40,000
| New | +$1.93M |
|